vs
Side-by-side financial comparison of ARCBEST CORP (ARCB) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $998.8M, roughly 1.5× ARCBEST CORP). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -0.1%, a 4.5% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 3.3%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -3.7%).
ArcBest Corporation is a leading U.S.-based logistics and transportation solutions provider. It offers end-to-end supply chain services including less-than-truckload freight shipping, full truckload services, warehousing, expedited delivery, and customized logistics consulting, serving enterprise, small business, and government clients across North America and select global markets.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
ARCB vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $998.8M | $1.5B |
| Net Profit | $-1.0M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 0.3% | 12.4% |
| Net Margin | -0.1% | 4.4% |
| Revenue YoY | 3.3% | 32.8% |
| Net Profit YoY | -133.1% | 143.8% |
| EPS (diluted) | $-0.05 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $998.8M | — | ||
| Q4 25 | $972.7M | $1.5B | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $967.1M | $1.1B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $1.1B | $1.0B | ||
| Q2 24 | $1.1B | $929.2M |
| Q1 26 | $-1.0M | — | ||
| Q4 25 | $-8.1M | $66.5M | ||
| Q3 25 | $39.3M | $124.8M | ||
| Q2 25 | $25.8M | $94.3M | ||
| Q1 25 | $3.1M | $1.3M | ||
| Q4 24 | $29.0M | $-151.9M | ||
| Q3 24 | $100.3M | $-121.3M | ||
| Q2 24 | $46.9M | $-120.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% |
| Q1 26 | 0.3% | — | ||
| Q4 25 | -0.8% | 12.4% | ||
| Q3 25 | 5.2% | 11.5% | ||
| Q2 25 | 3.6% | 6.7% | ||
| Q1 25 | 0.7% | 1.0% | ||
| Q4 24 | 3.8% | -7.0% | ||
| Q3 24 | 12.7% | -12.0% | ||
| Q2 24 | 4.5% | -11.5% |
| Q1 26 | -0.1% | — | ||
| Q4 25 | -0.8% | 4.4% | ||
| Q3 25 | 3.7% | 8.8% | ||
| Q2 25 | 2.5% | 7.2% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 2.9% | -13.5% | ||
| Q3 24 | 9.4% | -12.1% | ||
| Q2 24 | 4.4% | -13.0% |
| Q1 26 | $-0.05 | — | ||
| Q4 25 | $-0.35 | $0.05 | ||
| Q3 25 | $1.72 | $0.08 | ||
| Q2 25 | $1.12 | $0.06 | ||
| Q1 25 | $0.13 | $0.00 | ||
| Q4 24 | $1.21 | $-0.10 | ||
| Q3 24 | $4.23 | $-0.09 | ||
| Q2 24 | $1.96 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.4M | $4.5B |
| Total DebtLower is stronger | $223.7M | $836.4M |
| Stockholders' EquityBook value | $1.3B | $4.4B |
| Total Assets | $2.5B | $8.2B |
| Debt / EquityLower = less leverage | 0.17× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $86.4M | — | ||
| Q4 25 | $124.2M | $4.5B | ||
| Q3 25 | $132.6M | $4.0B | ||
| Q2 25 | $139.7M | $2.8B | ||
| Q1 25 | $98.7M | $2.5B | ||
| Q4 24 | $157.2M | $2.6B | ||
| Q3 24 | $191.1M | $2.7B | ||
| Q2 24 | $260.5M | $2.6B |
| Q1 26 | $223.7M | — | ||
| Q4 25 | — | $836.4M | ||
| Q3 25 | $214.1M | — | ||
| Q2 25 | $241.4M | — | ||
| Q1 25 | $214.2M | — | ||
| Q4 24 | $189.1M | — | ||
| Q3 24 | $180.5M | — | ||
| Q2 24 | $203.6M | — |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $4.4B | ||
| Q3 25 | $1.3B | $4.1B | ||
| Q2 25 | $1.3B | $3.8B | ||
| Q1 25 | $1.3B | $3.5B | ||
| Q4 24 | $1.3B | $3.3B | ||
| Q3 24 | $1.3B | $3.4B | ||
| Q2 24 | $1.2B | $3.4B |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $8.2B | ||
| Q3 25 | $2.5B | $7.6B | ||
| Q2 25 | $2.5B | $6.3B | ||
| Q1 25 | $2.4B | $5.8B | ||
| Q4 24 | $2.4B | $5.9B | ||
| Q3 24 | $2.4B | $5.8B | ||
| Q2 24 | $2.4B | $5.7B |
| Q1 26 | 0.17× | — | ||
| Q4 25 | — | 0.19× | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.17× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $44.7M | $417.3M | ||
| Q3 25 | $98.2M | $402.6M | ||
| Q2 25 | $108.4M | $263.6M | ||
| Q1 25 | $-22.3M | $44.1M | ||
| Q4 24 | $56.8M | $75.2M | ||
| Q3 24 | $88.8M | $188.4M | ||
| Q2 24 | $133.7M | $-95.6M |
| Q1 26 | — | — | ||
| Q4 25 | $36.9M | $379.8M | ||
| Q3 25 | $33.2M | $354.5M | ||
| Q2 25 | $80.9M | $219.8M | ||
| Q1 25 | $-36.8M | $-12.3M | ||
| Q4 24 | $3.5M | $-17.3M | ||
| Q3 24 | $23.9M | $54.7M | ||
| Q2 24 | $83.9M | $-205.5M |
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | 25.4% | ||
| Q3 25 | 3.2% | 25.1% | ||
| Q2 25 | 7.9% | 16.7% | ||
| Q1 25 | -3.8% | -1.1% | ||
| Q4 24 | 0.4% | -1.5% | ||
| Q3 24 | 2.2% | 5.5% | ||
| Q2 24 | 7.8% | -22.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.8% | 2.5% | ||
| Q3 25 | 6.2% | 3.4% | ||
| Q2 25 | 2.7% | 3.3% | ||
| Q1 25 | 1.5% | 5.0% | ||
| Q4 24 | 5.3% | 8.2% | ||
| Q3 24 | 6.1% | 13.3% | ||
| Q2 24 | 4.6% | 11.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.28× | ||
| Q3 25 | 2.50× | 3.22× | ||
| Q2 25 | 4.20× | 2.79× | ||
| Q1 25 | -7.13× | 34.71× | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 2.85× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
